The war against heart failure: The Lancet lecture

The Lancet

Volumn 385, Issue 9970, 2015, Pages 812-824

  Braunwald, Eugene ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; MICRORNA; UNTRANSLATED RNA;

ADIPOSE DERIVED STEM CELL; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIAC STEM CELL; CELL THERAPY; CRYOPRESERVATION; GENE EXPRESSION; GENE THERAPY; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MESENCHYME CELL; META ANALYSIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SARCOPLASMIC RETICULUM; BIOLOGICAL THERAPY; HEART ASSIST DEVICE; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY; PROCEDURES;

CALCIUM; CELL- AND TISSUE-BASED THERAPY; GENETIC THERAPY; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MICRORNAS; MYOCYTES, CARDIAC;

EID: 84925581948     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61889-4     Document Type: Review

References (159)

1. K Smolina, FL Wright, M Rayner, MJ Goldacre Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study BMJ 344 2012 d8059
2. AS Go, D Mozaffarian, VL Roger et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e282 e292
3. R Lozano, M Naghavi, K Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
4. AP Ambrosy, GC Fonarow, J Butler et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries J Am Coll Cardiol 63 2014 1123 1133
5. MD Huffman, D Prabhakaran Heart failure: epidemiology and prevention in India Natl Med J India 23 2010 283 288
6. M Nichols, N Townsend, P Scarborough, M Rayner Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009 Eur Heart J 34 2013 3017 3027
7. VL Roger Epidemiology of heart failure Circ Res 113 2013 646 659
8. AE Moran, MH Forouzanfar, GA Roth et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study Circulation 129 2014 1493 1501
9. AS Go, D Mozaffarian, VL Roger the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 292
10. R Vigen, TM Maddox, LA Allen Aging of the United States population: impact on heart failure Curr Heart Fail Rep 9 2012 369 374
11. JJV McMurray, S Adamopoulos, SD Anker the ESC Committee for Practice Guidelines ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
12. CW Yancy, M Jessup, B Bozkurt the American College of Cardiology Foundation the American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
13. K MacIntyre, S Capewell, S Stewart et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995 Circulation 102 2000 1126 1131
14. JJ McMurray, M Packer, AS Desai the PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
15. M Gheorghiade, F Zannad, G Sopko the International Working Group on Acute Heart Failure Syndromes Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
16. GC Fonarow, WT Abraham, NM Albert the OPTIMIZE-HF Investigators and Hospitals Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF Arch Intern Med 168 2008 847 854
17. JG Cleland, T McDonagh, AS Rigby, A Yassin, T Whittaker, HJ Dargie the National Heart Failure Audit Team for England and Wales The national heart failure audit for England and Wales 2008-2009 Heart 97 2011 876 886
18. K Guha, T McDonagh Heart failure epidemiology: European perspective Curr Cardiol Rev 9 2013 123 127
19. J Chen, SL Normand, Y Wang, HM Krumholz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
20. S Yusuf, S Rangarajan, K Teo the PURE Investigators Cardiovascular risk and events in 17 low-, middle-, and high-income countries N Engl J Med 371 2014 818 827
21. DM Bers, TR Shannon Calcium movements inside the sarcoplasmic reticulum of cardiac myocytes J Mol Cell Cardiol 58 2013 59 66
22. LH Opie, DM Bers Mechanisms of cardiac contraction and relaxation DL Mann DP Zipes P Libby RO Bonow Braunwald's Heart Disease 10th edn. 2015 Elsevier Philadelphia 429 453
23. AR Marks Calcium cycling proteins and heart failure: mechanisms and therapeutics J Clin Invest 123 2013 46 52
24. 2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload J Am Coll Cardiol 63 2014 1569 1579
25. AE Belevych, D Terentyev, R Terentyeva et al. The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function Cardiovasc Res 90 2011 493 502
26. SO Marx, AR Marks Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases J Mol Cell Cardiol 58 2013 225 231
27. ST Pleger, P Raake, HA Katus, P Most Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosome Circ Res 114 2014 12 14
28. M Meyer, W Schillinger, B Pieske et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy Circulation 92 1995 778 784
29. 2+ handling in heart failure Circ Res 113 2013 690 708
30. IAW van Rijsingen, PA van der Zwaag, JA Groeneweg et al. Outcome in phospholamban R14del carriers: results of a large multicentre cohort study Circ Cardiovasc Genet 7 2014 455 465
31. MK Bennett, WE Sweet, S Baicker-McKee et al. S100A1 in human heart failure: lack of recovery following left ventricular assist device support Circ Heart Fail 7 2014 612 618
32. 2+ leak in heart failure Circ Res 97 2005 1314 1322
33. T Zhang, LS Maier, ND Dalton et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure Circ Res 92 2003 912 919
34. JL Respress, RJ van Oort, N Li et al. Role of RyR2 phosphorylation at S2814 during heart failure progression Circ Res 110 2012 1474 1483
35. FI Malik, JJ Hartman, KA Elias et al. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure Science 331 2011 1439 1443
36. JGF Cleland, JR Teerlink, R Senior et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial Lancet 378 2011 676 683
37. N Miller Glybera and the future of gene therapy in the European Union Nat Rev Drug Discov 11 2012 419
38. S Daya, KI Berns Gene therapy using adeno-associated virus vectors Clin Microbiol Rev 21 2008 583 593
39. ST Pleger, H Brinks, J Ritterhoff et al. Heart failure gene therapy: the path to clinical practice Circ Res 113 2013 792 809
40. V Louis Jeune, JA Joergensen, RJ Hajjar, T Weber Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy Hum Gene Ther Methods 24 2013 59 67
41. F del Monte, SE Harding, U Schmidt et al. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a Circulation 100 1999 2308 2311
42. MI Miyamoto, F del Monte, U Schmidt et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure Proc Natl Acad Sci USA 97 2000 793 798
43. Y Kawase, HQ Ly, F Prunier et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure J Am Coll Cardiol 51 2008 1112 1119
44. R Beeri, M Chaput, JL Guerrero et al. Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation Circ Heart Fail 3 2010 627 634
45. MJ Byrne, JM Power, A Preovolos, JA Mariani, RJ Hajjar, DM Kaye Recirculating cardiac delivery of AAV2/SERCA2a improves myocardial function in an experimental model of heart failure in large animals Gene Ther 15 2008 1550 1557
46. BE Jaski, ML Jessup, DM Mancini the Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID) Trial Investigators Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181
47. 2+-ATPase in patients with advanced heart failure Circulation 124 2011 304 313
48. K Zsebo, A Yaroshinsky, JJ Rudy et al. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality Circ Res 114 2014 101 108
49. B Greenberg, A Yaroshinsky, KM Zsebo et al. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b) JACC Heart Fail 2 2014 84 92
50. F del Monte, SE Harding, GW Dec, JK Gwathmey, RJ Hajjar Targeting phospholamban by gene transfer in human heart failure Circulation 105 2002 904 907
51. DM Kaye, A Preovolos, T Marshall et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals J Am Coll Cardiol 50 2007 253 260
52. J Ritterhoff, P Most Targeting S100A1 in heart failure Gene Ther 19 2012 613 621
53. H Brinks, D Rohde, M Voelkers et al. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes J Am Coll Cardiol 58 2011 966 973
54. ST Pleger, P Most, M Boucher et al. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue Circulation 115 2007 2506 2515
55. MR Bristow, R Ginsburg, W Minobe et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 307 1982 205 211
56. S Engelhardt, L Hein, V Dyachenkow, EG Kranias, G Isenberg, MJ Lohse Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation Circulation 109 2004 1154 1160
57. AS Shah, RE Lilly, AP Kypson et al. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart: prospects for molecular ventricular assistance Circulation 101 2000 408 414
58. JA Hata, ML Williams, WJ Koch Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization J Mol Cell Cardiol 37 2004 11 21
59. NC Lai, DM Roth, MH Gao et al. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure Circulation 110 2004 330 336
60. WJ Koch, HA Rockman, P Samama et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor Science 268 1995 1350 1353
61. H Brinks, WJ Koch betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease J Cardiovasc Transl Res 3 2010 499 506
62. PW Raake, P Schlegel, J Ksienzyk et al. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model Eur Heart J 34 2013 1437 1447
63. T Tang, MH Gao, HK Hammond Prospects for gene transfer for clinical heart failure Gene Ther 19 2012 606 612
64. RC Lee, RL Feinbaum, V Ambros The C. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 1993 843 854
65. B Wightman, I Ha, G Ruvkun Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. Elegans Cell 75 1993 855 862
66. G Condorelli, MVG Latronico, E Cavarretta microRNAs in cardiovascular diseases: current knowledge and the road ahead J Am Coll Cardiol 63 2014 2177 2187
67. YF Melman, R Shah, S Das MicroRNAs in heart failure: is the picture becoming less miRky? Circ Heart Fail 7 2014 203 214
68. R Kumarswamy, T Thum Non-coding RNAs in cardiac remodeling and heart failure Circ Res 113 2013 676 689
69. P Gurha, C Abreu-Goodger, T Wang et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction Circulation 125 2012 2751 2761
70. E van Rooij, LB Sutherland, X Qi, JA Richardson, J Hill, EN Olson Control of stress-dependent cardiac growth and gene expression by a microRNA Science 316 2007 575 579
71. TE Callis, K Pandya, HY Seok et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J Clin Invest 119 2009 2772 2786
72. E van Rooij, EN Olson MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles Nat Rev Drug Discov 11 2012 860 872
73. HLA Janssen, HW Reesink, EJ Lawitz et al. Treatment of HCV infection by targeting microRNA N Engl J Med 368 2013 1685 1694
74. A Carè, D Catalucci, F Felicetti et al. MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
75. R Kumarswamy, AR Lyon, I Volkmann et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway Eur Heart J 33 2012 1067 1075
76. A Castaldi, T Zaglia, V Di Mauro et al. MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade Circ Res 115 2014 273 283
77. RL Montgomery, TG Hullinger, HM Semus et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure Circulation 124 2011 1537 1547
78. BC Bernardo, XM Gao, CE Winbanks et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function Proc Natl Acad Sci USA 109 2012 17615 17620
79. C Wahlquist, D Jeong, A Rojas-Muñoz et al. Inhibition of miR-25 improves cardiac contractility in the failing heart Nature 508 2014 531 535
80. SJ Matkovich, Y Hu, WH Eschenbacher, LE Dorn, GW Dorn 2nd Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy Circ Res 111 2012 521 531
81. D Quiat, EN Olson MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment J Clin Invest 123 2013 11 18
82. T Thum, N Chau, B Bhat et al. Comparison of different miR-21 inhibitor chemistries in a cardiac disease model J Clin Invest 121 2011 461 462 author reply 462-63.
83. E van Rooij, LB Sutherland, JE Thatcher et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci USA 105 2008 13027 13032
84. PS Mitchell, RK Parkin, EM Kroh et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci USA 105 2008 10513 10518
85. AJ Tijsen, EE Creemers, PD Moerland et al. MiR423-5p as a circulating biomarker for heart failure Circ Res 106 2010 1035 1039
86. S Matsumoto, Y Sakata, S Suna et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction Circ Res 113 2013 322 326
87. B Vogel, A Keller, KS Frese et al. Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure Eur Heart J 34 2013 2812 2822
88. LO Jacobson, EL Simmons, EK Marks, MJ Robson, WF Bethard, EO Gaston The role of the spleen in radiation injury and recovery J Lab Clin Med 35 1950 746 770
89. M Eghbali, R Tomek, C Woods, B Bhambi Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta Proc Natl Acad Sci USA 88 1991 795 799
90. S Tomita, RK Li, RD Weisel et al. Autologous transplantation of bone marrow cells improves damaged heart function Circulation 100 suppl 1999 II247 II256
91. D Orlic, J Kajstura, S Chimenti et al. Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
92. SK Sanganalmath, R Bolli Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions Circ Res 113 2013 810 834
93. P Menasché, O Alfieri, S Janssens et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
94. MY Emmert, RW Hitchcock, SP Hoerstrup Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration Adv Drug Deliv Rev 69-70 2014 254 269
95. KS Telukuntla, VY Suncion, IH Schulman, JM Hare The advancing field of cell-based therapy: insights and lessons from clinical trials J Am Heart Assoc 2 2013 e000338
96. JJH Chong, X Yang, CW Don et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts Nature 510 2014 273 277
97. SD Schwartz, J-P Hubschman, G Heilwell et al. Embryonic stem cell trials for macular degeneration: a preliminary report Lancet 379 2012 713 720
98. F Bretzner, F Gilbert, F Baylis, RM Brownstone Target populations for first-in-human embryonic stem cell research in spinal cord injury Cell Stem Cell 8 2011 468 475
99. K Takahashi, S Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
100. I Acimovic, A Vilotic, M Pesl et al. Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools BioMed Res Int 2014 Article ID 512831.
101. Q Xiong, L Ye, P Zhang et al. Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling Circulation 127 2013 997 1008
102. L Zhang, Y Pan, G Qin et al. Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium Cell Cycle 13 2014 762 771
103. MI Phillips Tumor-free iPS stem cells for heart cells Cell Cycle 13 2014 1519
104. H Wang, N Cao, CI Spencer et al. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct 4 Cell Reports 6 2014 951 960
105. M Gnecchi, Z Zhang, A Ni, VJ Dzau Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 2008 1204 1219
106. O Pfister, G Della Verde, R Liao, GM Kuster Regenerative therapy for cardiovascular disease Transl Res 163 2014 307 320
107. B Assmus, DM Leistner, V Schächinger the REPAIR-AMI Study Group Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival Eur Heart J 35 2014 1275 1283
108. V Jeevanantham, M Butler, A Saad, A Abdel-Latif, EK Zuba-Surma, B Dawn Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis Circulation 126 2012 551 568
109. DM Clifford, SA Fisher, SJ Brunskill et al. Stem cell treatment for acute myocardial infarction Cochrane Database Syst Rev 2 2012 CD006536.
110. C Toma, MF Pittenger, KS Cahill, BJ Byrne, PD Kessler Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 2002 93 98
111. HC Quevedo, KE Hatzistergos, BN Oskouei et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity Proc Natl Acad Sci USA 106 2009 14022 14027
112. AW Heldman, DL DiFede, JE Fishman et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial JAMA 311 2014 62 73
113. J Bartunek, A Behfar, D Dolatabadi et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics J Am Coll Cardiol 61 2013 2329 2338
114. JM Hare, JE Fishman, G Gerstenblith et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial JAMA 308 2012 2369 2379
115. DD Ascheim, AC Gelijns, D Goldstein et al. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices Circulation 129 2014 2287 2296
116. V Planat-Bénard, C Menard, M André et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells Circ Res 94 2004 223 229
117. M Mazo, V Planat-Bénard, G Abizanda et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction Eur J Heart Fail 10 2008 454 462
118. EC Perin, R Sanz-Ruiz, PL Sánchez et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial Am Heart J 168 2014 88 95 e2.
119. RK Li, ZQ Jia, RD Weisel et al. Cardiomyocyte transplantation improves heart function Ann Thorac Surg 62 1996 654 660 discussion 660-61.
120. AM Hierlihy, P Seale, CG Lobe, MA Rudnicki, LA Megeney The post-natal heart contains a myocardial stem cell population FEBS Lett 530 2002 239 243
121. AP Beltrami, L Barlucchi, D Torella et al. Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
122. Q Li, Y Guo, Q Ou et al. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models Basic Res Cardiol 106 2011 849 864
123. HC Ott, TS Matthiesen, J Brechtken et al. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells Nat Clin Pract Cardiovasc Med 4 suppl 1 2007 S27 S39
124. E Messina, L De Angelis, G Frati et al. Isolation and expansion of adult cardiac stem cells from human and murine heart Circ Res 95 2004 911 921
125. RR Smith, L Barile, HC Cho et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens Circulation 115 2007 896 908
126. PV Johnston, T Sasano, K Mills et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy Circulation 120 2009 1075 1083
127. RR Makkar, RR Smith, K Cheng et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
128. K Malliaras, RR Makkar, RR Smith et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) J Am Coll Cardiol 63 2014 110 122
129. K Malliaras, T-S Li, D Luthringer et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells Circulation 125 2012 100 112
130. S Mohsin, M Khan, J Nguyen et al. Rejuvenation of human cardiac progenitor cells with Pim-1 kinase Circ Res 113 2013 1169 1179
131. JD Hill Bridging to cardiac transplantation Ann Thorac Surg 47 1989 167 171
132. EA Rose, AC Gelijns, AJ Moskowitz the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
133. JK Kirklin, DC Naftel, FD Pagani et al. Sixth INTERMACS annual report: a 10,000-patient database J Heart Lung Transplant 33 2014 555 564
134. D Feldman, SV Pamboukian, JJ Teuteberg the International Society for Heart and Lung Transplantation The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary J Heart Lung Transplant 32 2013 157 187
135. JK Kirklin, DC Naftel, FD Pagani et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 144 2012 584 603
136. P Khazanie, BG Hammill, CB Patel et al. Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011 J Am Coll Cardiol 63 2014 1395 1404
137. MS Slaughter, FD Pagani, EC McGee the HeartWare Bridge to Transplant ADVANCE Trial Investigators HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
138. A Lala, E Joyce, JD Groarke, MR Mehra Challenges in long-term mechanical circulatory support and biological replacement of the failing heart Circ J 78 2014 288 299
139. RC Starling, N Moazami, SC Silvestry et al. Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
140. HR Levin, MC Oz, JM Chen, M Packer, EA Rose, D Burkhoff Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading Circulation 91 1995 2717 2720
141. OH Frazier, CR Benedict, B Radovancevic et al. Improved left ventricular function after chronic left ventricular unloading Ann Thorac Surg 62 1996 675 681 discussion 681-82.
142. K Dipla, JA Mattiello, V Jeevanandam, SR Houser, KB Margulies Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure Circulation 97 1998 2316 2322
143. EJ Birks Molecular changes after left ventricular assist device support for heart failure Circ Res 113 2013 777 791
144. A Rodrigue-Way, D Burkhoff, BJ Geesaman et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support J Heart Lung Transplant 24 2005 73 80
145. G Torre-Amione, SJ Stetson, KA Youker et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery Circulation 100 1999 1189 1193
146. DA Liem, A Nsair, SP Setty et al. Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support Circ Heart Fail 7 2014 359 366
147. GE Burch, JJ Walsh, VJ Ferrans, R Hibbs Prolonged bed rest in the treatment of the dilated heart Circulation 32 1965 852 856
148. DL Mann, PM Barger, D Burkhoff Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol 60 2012 2465 2472
149. J Müller, G Wallukat, YG Weng et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy Circulation 96 1997 542 549
150. OH Frazier, TJ Myers Left ventricular assist system as a bridge to myocardial recovery Ann Thorac Surg 68 1999 734 741
151. MH Yacoub A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery Eur Heart J 22 2001 534 540
152. EJ Birks, PD Tansley, J Hardy et al. Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
153. M Pokorný, L Cervenka, I Netuka, J Pirk, M Koňařík, J Malý Ventricular assist devices in heart failure: how to support the heart but prevent atrophy? Physiol Res 63 2014 147 156
154. EJ Birks, RS George, M Hedger et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 2011 381 390
155. EJ Birks, RS George, A Firouzi et al. Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation J Thorac Cardiovasc Surg 144 2012 190 196
156. M Dandel, Y Weng, H Siniawski et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices Circulation 126 suppl 1 2012 S9 S19
157. AJ Lenneman, EJ Birks Treatment strategies for myocardial recovery in heart failure Curr Treat Options Cardiovasc Med 16 2014 287
158. DD Schocken, EJ Benjamin, GC Fonarow the American Heart Association Council on Epidemiology and Prevention the American Heart Association Council on Clinical Cardiology the American Heart Association Council on Cardiovascular Nursing the American Heart Association Council on High Blood Pressure Research the Quality of Care and Outcomes Research Interdisciplinary Working Group the Functional Genomics and Translational Biology Interdisciplinary Working Group Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation 117 2008 2544 2565
159. SK Ganesh, DK Arnett, TL Assimes the American Heart Association Council on Functional Genomics and Translational Biology the American Heart Association Council on Epidemiology and Prevention the American Heart Association Council on Basic Cardiovascular Sciences the American Heart Association Council on Cardiovascular Disease in the Young the American Heart Association Council on Cardiovascular and Stroke Nursing the American Heart Association Stroke Council Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association Circulation 128 2013 2813 2851